These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

150 related items for PubMed ID: 8222167

  • 1. Captopril reduces graft coronary artery disease in a rat heterotopic transplant model.
    Kobayashi J, Crawford SE, Backer CL, Zales VR, Takami H, Hsueh C, Huang L, Mavroudis C.
    Circulation; 1993 Nov; 88(5 Pt 2):II286-90. PubMed ID: 8222167
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Electroporation-mediated interleukin-10 overexpression in skeletal muscle reduces acute rejection in rat cardiac allografts.
    Tavakoli R, Gazdhar A, Pierog J, Bogdanova A, Gugger M, Pringle IA, Gill DR, Hyde SC, Genoni M, Schmid RA.
    J Gene Med; 2006 Feb; 8(2):242-8. PubMed ID: 16389627
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Two good reasons for an angiotensin-II type 1 receptor blockade with losartan after cardiac transplantation: reduction of incidence and severity of transplant vasculopathy.
    Richter MH, Richter HR, Olbrich HG, Mohr FW.
    Transpl Int; 2003 Jan; 16(1):26-32. PubMed ID: 12545338
    [Abstract] [Full Text] [Related]

  • 8. Prolonged cold ischemic times and less donor-recipient histocompatibility accelerate graft vascular disease.
    Czer LS, Wong AV, Soukiasian H, Gallagher S, De Robertis M, Trento A.
    Transplant Proc; 2011 Dec; 43(10):3863-8. PubMed ID: 22172861
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Inhibition of heart transplant injury and graft coronary artery disease after prolonged organ ischemia by selective protein kinase C regulators.
    Tanaka M, Gunawan F, Terry RD, Inagaki K, Caffarelli AD, Hoyt G, Tsao PS, Mochly-Rosen D, Robbins RC.
    J Thorac Cardiovasc Surg; 2005 May; 129(5):1160-7. PubMed ID: 15867794
    [Abstract] [Full Text] [Related]

  • 11. Angiotensin II receptor antagonist TCV-116 reduces graft coronary artery disease and preserves graft status in a murine model. A comparative study with captopril.
    Furukawa Y, Matsumori A, Hirozane T, Sasayama S.
    Circulation; 1996 Jan 15; 93(2):333-9. PubMed ID: 8548907
    [Abstract] [Full Text] [Related]

  • 12. A new rat infection-heart transplant model: effect of infection on graft survival studies.
    Kobayashi J, Mavroudis C, Crawford SE, Zales VR, Backer CL.
    J Heart Lung Transplant; 1993 Jan 15; 12(4):659-64. PubMed ID: 7690253
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Inhibition of graft coronary arteriosclerosis after heart transplantation.
    Soukiasian HJ, Czer LS, Wang HM, Luthringer D, Wang C, Kamlot A, Quartel A, Trento A.
    Am Surg; 2004 Oct 15; 70(10):833-40. PubMed ID: 15529833
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Low molecular weight fucan prevents transplant coronaropathy in rat cardiac allograft model.
    Alkhatib B, Freguin-Bouilland C, Lallemand F, Henry JP, Litzler PY, Marie JP, Richard V, Thuillez C, Plissonnier D.
    Transpl Immunol; 2006 Jun 15; 16(1):14-9. PubMed ID: 16701171
    [Abstract] [Full Text] [Related]

  • 18. Effect of single-dose rapamycin-based immunosuppression on the development of cardiac allograft vasculopathy.
    Goggins WC, Fisher RA, Cohen DS, Tawes JW, Grimes MM.
    J Heart Lung Transplant; 1996 Aug 15; 15(8):790-5. PubMed ID: 8878761
    [Abstract] [Full Text] [Related]

  • 19. Different immune effects on cardiac allografts and xenografts induced by neonatal intrathymic inoculation with allogeneic and xenogeneic antigens.
    Shen Z, Pelletier S, Mohiuddin M, Yokoyama H, Reiss GR, DiSesa VJ.
    J Heart Lung Transplant; 1996 Oct 15; 15(10):1034-8. PubMed ID: 8913921
    [Abstract] [Full Text] [Related]

  • 20. Low-dose cyclosporine treatment fails to prevent coronary luminal narrowing after heart transplantation.
    Vassalli G, Kaski JC, Tousoulis D, Kiowski W, Turina M, Follath F, Gallino A.
    J Heart Lung Transplant; 1996 Jun 15; 15(6):612-9. PubMed ID: 8794036
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.